Business / Finance

RSS

Provectus’ shares to begin trading on NYSE MKT on May 16, 2014

Provectus Biopharmaceuticals, Inc., a development-stage oncology and dermatology biopharmaceutical company, announced that its shares will begin trading on the NYSE MKT today, Friday, May 16, 2014.

16 May 2014

Kymab raises US$40 million in Series B financing

Kymab, a monoclonal antibody biopharmaceutical company, announced today it has successfully raised US$40 million in a Series B financing.

16 May 2014

Standard & Poor's upgrades HTA's investment grade credit rating to BBB

Healthcare Trust of America, Inc. (NYSE: HTA) announced today that Standard & Poor's ("S&P") has upgraded HTA's investment grade credit rating to BBB, with a stable outlook.

16 May 2014

Agfa HealthCare launches ICIS for mobile and web capture at SIIM 2014, extending the "Evolution of Visual Healthcare" to smart phones and tablets

Extending the "Evolution of Visual Healthcare" to mobile devices, Agfa HealthCare announced today the launch of its new web-enabled mobile image management technology that brings the power of ICIS to iPhones, iPads, Web, and Android mobile digital devices.

15 May 2014

Actavis reaches agreement to continue supplying authorized generic version of JPI's Concerta

Actavis plc today announced that it has reached an agreement with Janssen Pharmaceuticals, Inc. to continue supplying the authorized generic version of JPI's Concerta (methylphenidate hydrochloride extended-release tablets).

15 May 2014

Cord Blood America's total revenue decreases 3% to $1.42 million in Q1 2014

Cord Blood America, Inc. today announced financial results for the quarter ended March 31, 2014.

15 May 2014

Inspire Medical Systems completes $40 million Series E financing

Inspire Medical Systems, Inc. announced today that it has completed a Series E financing of $40 million. The financing round was strategically timed to coincide with the commercial launch of the Inspire Upper Airway Stimulation (UAS) therapy in the United States.

15 May 2014

ERBA Diagnostics reports decrease in Q1 2014 net revenues

ERBA Diagnostics, Inc., a fully integrated in vitro diagnostics company, reported its financial results for the three months ended March 31, 2014.

15 May 2014

Boston Scientific to acquire Bayer’s Interventional Division

In a move to expand significantly its portfolio of leading solutions for peripheral interventions, Boston Scientific Corporation has entered into a definitive agreement to acquire the Interventional Division of Bayer AG for $415 million in cash, including fees for transitional services.

15 May 2014

Eleven Biotherapeutics reports financial results and operational highlights for Q1 2014

Eleven Biotherapeutics, Inc., a clinical-stage biopharmaceutical company discovering and developing protein therapeutics to treat diseases of the eye, today reported financial results and operational highlights for the quarter ended March 31, 2014.

15 May 2014

EntreMed reports net loss of $1.5M in first quarter 2014

EntreMed, Inc., a clinical-stage pharmaceutical company developing therapeutics for the treatment of cancer and other diseases, today reported financial results for the three months ended March 31, 2014.

15 May 2014

Isis Pharmaceuticals receives $3 million milestone payment from GSK

Isis Pharmaceuticals, Inc. announced today that it has earned a $3.0 million milestone payment from GlaxoSmithKline (GSK) related to the initiation of a natural history study, which will support the advancement of one of the alliance programs.

15 May 2014

Kindred Healthcare proposes to acquire all outstanding shares of Gentiva

Kindred Healthcare, Inc. ("Kindred" or the "Company") today announced a proposal to acquire all of the outstanding shares of common stock of Gentiva Health Services, Inc.

15 May 2014

China Pharma Holdings' revenue decreases 14% to $7.1 million in first quarter 2014

China Pharma Holdings, Inc., an NYSE MKT listed corporation with its fully-integrated specialty pharmaceuticals subsidiary based in China, today announced its financial results for the three months ended March 31, 2014.

15 May 2014

Prestige Brands’ net revenues decrease $144.3M to 6.6% in Q4 and FY 2014

Prestige Brands Holdings, Inc. ("the Company") today announced results for the fourth quarter and the fiscal year ended March 31, 2014.

15 May 2014

Virtualscopics reports record revenues in first quarter 2014

VirtualScopics, Inc., a leading provider of quantitative imaging solutions, today reported the financial results for the first quarter ended March 31, 2014.

15 May 2014

Rep. Jan Schakowsky visits Wockhardt plant, commends production expansion in Illinois

Rep. Jan Schakowsky visited Wockhardt's Morton Grove facility with a goal in mind: strengthening efforts to revitalize American manufacturing.

15 May 2014

National Mentor’s revenue increases $309.8M to 4.8% in Q2 2014

National Mentor Holdings, Inc. (the "Company") today announced its financial results for the second quarter ended March 31, 2014.

15 May 2014

Sorrento Therapeutics prices underwritten public offering of 4,765,000 shares of common stock

Sorrento Therapeutics, Inc. ("Sorrento" or the "Company"), a late-stage clinical oncology company developing new treatments for cancer and its associated pain, today announced the pricing of an underwritten public offering of 4,765,000 shares of common stock at a public offering price of $5.25 per share.

15 May 2014

Introduction to Solid State ChIP technology

A new instructional video from Porvair Sciences explains exactly how to conduct a ChIP assay for epigenetic research starting from a confluent monolayer of human cells.

From Chromatrap® - Porvair Sciences Ltd 14 May 2014